Article

Senofilcon A lenses may help reduce contact discomfort

Jacksonville, FL?A new study shows that soft contact lenses made with senofilcon A, a new-generation silicone hydrogel material, were associated with a reduction in discomfort, dryness, and other commonly reported problems associated with contact lens wear. Contact lenses made with senofilcon A are currently marketed in the United States under the name Acuvue Oasys Brand Contact Lenses with Hydraclear Plus.

Jacksonville, FL-A new study shows that soft contact lenses made with senofilcon A, a new-generation silicone hydrogel material, were associated with a reduction in discomfort, dryness, and other commonly reported problems associated with contact lens wear. Contact lenses made with senofilcon A are currently marketed in the United States under the name Acuvue Oasys Brand Contact Lenses with Hydraclear Plus.

Problems with discomfort and dryness affect approximately 67% of the more than 36 million contact lens wearers in the United States, with about four in 10 (42%) wearers reporting that they use rewetting drops at least once a day to keep their eyes from feeling dry. And, while 3 million people a year become new contact lens wearers, studies suggest that during the same period approximately 2.7 million people stop wearing contact lenses, with one in four (24%) citing dry, challenging environments or wearing conditions as reasons for discontinuing contact lens wear.

The study was sponsored by Vistakon, a division of Johnson & Johnson Vision Care Inc., marketer of Acuvue Oasys.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
© 2025 MJH Life Sciences

All rights reserved.